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Impaired renal acidification following acute renal ischemia in the dog.
Transient renal tubular acidosis may complicate acute renal failure
(ARF). To clarify this phenomenon, the present study examined tubular
H ion secretory capacity in an ischemic model of ARF. Clearance
studies were performed in dogs subjected to 60 minutes, unilateral renal
artery clamping. The contralateral kidney served as control. One hour
after release of clamp, mean glomerular filtration rate (GFR) was
reduced by 50 to 70 percent in the ischemic kidney. Bicarbonate
reclamation (mEq/liter GFR) was comparable in both kidneys. How-
ever, ischemia resulted in impaired distal acidification as judged by
three separate maneuvers: minimal urinary pH following sulphate
infusion was higher in ischemic than in control kidney (6.61 0.39 vs.
5.39 0.26, P < 0.01), mean urine to blood PCO2 difference (U-B
PCO2) was significantly lower during phosphate infusion (ischemic: 13.8
4.1 mm Hg, control: 37.2 6.8 mm Hg, P C 0.01) and was
completely abolished during isotonic NaHCO3 infusion in the ischemic
kidney (—1.9 3.4mm Hg) compared to control (40.1 14.8mm Hg,
P C 0.05). Urinary potassium excretion was intact following ischemia
and was appropriately suppressed by amiloride. Administration of 0.7 M
NaHCO3 solution at a rate sufficient to produce maximally alkaline
urine resulted in a similar U-B PCO2/UHCO3 relationship in both
kidneys in the face of impaired distal acidification in the ischemic
kidney. This suggests either that the defect may be reversed by massive
bicarbonate infusion or, alternatively, that U-B PCO2 difference may be
related to other factors in addition to distal Ht secretion. The data
demonstrate that acute renal ischemia in the dog is associated with a
defect in distal nephroo acidification, most likely of a secretory type.
Metabolic acidosis may be observed during the oliguric as
well as the recovery phase of acute tubular necrosis. The
impaired ability to eliminate hydrogen ions during acute renal
failure has been attributed, as in chronic renal failure, to the
generalized decrease in functional renal mass [11. However,
acute renal failure in man may be associated with a failure to
normally decrease urinary pH in the face of systemic acidosis
[2—51. This is in marked contrast to chronic renal failure, where
urinary pH remains usually below 5.5 to 5.0. Also, the recovery
of the capacity to acidify the urine may lag after the increase in
glomerular filtration rate. These two findings suggest that a
specific defect in H secretion occurs in acute renal failure and
thus aggravates the acidosis caused by the decrease in function-
ing nephrons. This possibility, although supported by data
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obtained in patients recovering from acute renal failure [2—51,
has hitherto not been explored in experimental models of acute
renal ischemia. Only one study [6j has evaluated tubular
acidification in glycerol—induced acute renal failure in the rat.
The finding of the latter implicates mainly the proximal nephron
as the site of impaired bicarbonate reabsorption.
The purpose of the present investigation was: 1.) to evaluate
tubular secretory capacity for H ions in an experimental model
of ischemic acute renal failure in the dog, and 2,) to study the
mechanism(s) of the deranged tubular acidification in this
model. Our data demonstrate that acute renal ischcmia in the
dog is associated with a tubular defect in H ion secretion
predominantly in the distal nephron.
Methods
Acute clearance studies were carried out on 31 mongrel dogs
of both sexes, weighing 14 to 24 kg. The animals ate a regular
diet and had free access to tap water until 16 hours before the
experiment.
Anesthesia was induced by i.v. pentobarbitone administra-
tion at 30 mg/kg (NembutaiR, Abbott Laboratories, North
Chicago, Illinois, USA). Additional small doses were given as
required to maintain light anesthesia throughout the experi-
ment. A cuffed endotracheal tube was inserted and connected
to a Harvard respirator. Arterial CO2 tension was kept at 35 to
45 mm Hg by appropriate manipulation of the respirator.
Polyethylene catheters were inserted into the right femoral
artery and vein. The arterial line was used for blood sampling
and blood pressure monitoring, and the venous catheter for
infusion of various solutions. A priming dose of inulin was
injected, followed by the infusion of a sustaining solution of
inulin in 0.9 percent saline at a rate of I mI/mm. The concen-
tration of inulin in this solution was calculated to establish a
blood level of 20 to 30 mg/l00 ml.
Both kidneys were exposed through a midline abdominal
incision and ureters were identified and cannulated. After
completion of the surgery, heparin 200 U/kg was given iv. in a
single bolus. The left renal artery was then mechanically
clamped for one hour.
Following release of the clamp, a recovery period of 60
minutes was allowed before urine collections were begun.
Towards the end of the recovery period, the following experi-
mental maneuvers were started:
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Group A: Sodium sulphate infusion
Six dogs were treated with fluorocortisone acetate tablets 0.1
mg (Florinef', E.R. Squibb & Sons, Inc., Princeton, New
Jersey, USA) per os, 16 hours prior to, and on the morning of
the experiment. The animals were then subjected to an acute
unilateral renal ischemia. Following a recovery period of 60
minutes, a solution of 0.1 M Na2SO4 was infused for two hours
at a rate of 3 mI/mm. Six to seven 20-minute clearance periods
were obtained during sulphate infusion. Urine was collected
separately from each ureter into graduated cylinders containing
mineral oil and were analyzed immediately for pH. Additional
samples were preserved for the determinations of urinary
ammonia concentration and titratable acid.
Group B: Phosphate buffer infusion
In this group, seven dogs received an infusion of 0.1 M neutral
phosphate solution (dibasic to monobasic phosphate molar ratio
of 4:1, pH 7.4) at a rate of 2 to 3 mllmin. As in the previous
experimental group, phosphate infusion began 60 minutes fol-
lowing the release of the renal artery clamp. Urine collections
were begun after achievement of stable urine pH. Urine and
blood samples obtained under anerobic conditions were then
analyzed for PCO2 and pH.
Group C: Isotonic bicarbonate infusion
A total of six animals received isotonic infusion of NaHCO3
(0.15 M) at a rate of up to 1 ml/min for two hours. The rate of
infusion was adjusted to equal urine flow and care was taken to
prevent expansion of the extracellular fluid. Urine was col-
lected under oil and analyzed immediately for pH and PCO2.
Six to seven urine collections of 20 minutes each were obtained.
Only samples which did not differ from the preceding urine
collection by more than 0.20 pH units were accepted, in order
to exclude generation of high urinary PCO2 from mixing of acid
and alkaline urines in the lower urinary tract.
Group D: "Hypertonic" bicarbonate infusion
After a one hour recovery period, six dogs received an
infusion of 0.7 M NaHCO3 solution at a rate of 3 mllmin for two
hours in order to achieve maximally alkaline urine. Urine
collections were obtained as in group C and urine losses were
replaced with the same solution at a slightly higher level to
maintain a volume expanded state.
Group E: "Hypertonic" bicarbonate infusion plus amiloride
Additional studies were carried out on six dogs that were
treated similarly to group D with the following exceptions:
thirty minutes after the initiation of inulin infusion, amiloride
dissolved in 0.225 percent sodium chloride was administered
intravenously as a priming dose (2 to 3 mg/kg body wt) over 10
to 15 minutes. This was followed by a sustaining infusion of 3 to
6 mg/kg/hr throughout the experiment. Thirty minutes later 0.7
M NaHCO3 solution was administered as reported for group D.
Four to five consecutive urine collections of 20 minutes each
were performed as in the other experimental groups.
Anerobic blood samples were obtained with heparinized
syringes at the midpoint of each urine collection and were
analyzed immediately for blood gases. Additional blood sam-
ples were taken every second urine collection for the determi-
nation of inulin and serum electrolytes.
Analytical methods
Inulin clearance was used to assess glomerular filtration rate.
The concentration of sodium and potassium in blood and urine
was measured by flame photometry. The method of Fiske and
Subbarow [71 was used to measure urinary phosphate.
Osmolality of serum and urine was determined cryoscopi-
cally using a Fiske automatic osmometer (Model 130, Fiske
Associates, Inc., Uxbridge, Massachusetts, USA).
The pH and PCO2 of blood and urine were measured in fresh
samples at 37°C with a digital acid base analyzer (Model BMS3,
Mk2, Radiometer, Copenhagen, Denmark). Plasma and urine
bicarbonate concentrations were calculated from the
Henderson—Hasselbalch equation using a solubility coefficient
of 0.0301 and pK of 6.10 for plasma. In the urine the pK' was
calculated from urinary ionic strength (pK' = 6.33 — 0.5
VNa + K), the concentrations of Na and K expressed in
equivalents per liter [81, and a solubility factor of 0.0309 was
used.
Urinary and plasma inulin as well as titratable acidity and
ammonia concentration in urine were determined by methods
previously reported from this laboratory [91.
Results are expressed as means Statistical significance
was assessed by Student's t-test for paired data (ischemic vs.
control kidney comparison) and for unpaired data (between
groups comparison). A P value less than 0.05 was considered
statistically significant. The regression lines were calculated by
the method of least squares. The slopes of the various regres-
sion lines were compared by the analysis of covariance [10].
Results
Table 1 presents the clearance data and electrolyte excretion
patterns in the experimental groups A to D. Urinary acidifica-
tion and bicarbonate excretion data are summarized in Tables 2
and 3.
Effect of ischemia on GFR and electrolyte excretion
Mean glomerular filtration rate, estimated by inulin clear-
ance, was reduced by 50 to 70 percent in the ischemic kidney of
all experimental groups compared to values obtained in the
control kidney (Table 1).
The effects of acute renal ischemia on tubular handling of
sodium and water may be properly assessed only in the group
infused with isotonic bicarbonate solution (group C). With the
exception of the latter group, where euvolemia was maintained,
all other experimental maneuvers, that is, Na2SO4, neutral
phosphate and 0.7 M NaHCO3 infusions, were associated with
various degrees of volume expansion which might have affected
sodium and water transport in the control kidney as well.
The data obtained in the euvolemic group C demonstrate an
impairment in sodium reabsorption following renal ischemia.
Thus, there was an increase in sodium excretion in the ischemic
kidney expressed in absolute terms (ischemic: 70.2 13.9
Eq/min, control: 32 9.9 pEq/min, P <0.05) as well as in the
fractional sodium excretion (ischemic: 8.1 2.4%, control: 0.93
0.31%, P < 0.02). In addition, acute ischemia resulted in a
defect in urinary concentrating ability; urine osmolarity was
significantly reduced in the ischemic kidney; 404 39.0
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Table 1. Clearance and urinary electrolyte excretion data in the our experimental groupsa
UOmC V UNaV %ENa UKV %EK mOsmi
mi/mm mi/mm p.Eq/min jtEqImin kgH2Q
C F C F. C E C F C E C E C E
A (N = 6)
0.1 M Na2SO4
Mean 17.0 8,7 0.62 0.60 122.5 94.6 5.0 7.3 20.4 14.6 41.4 64.7 599 396
SEM 2.7 2.6 0.15 0.28 24.0 41.3 0.9 1.4 3.1 3.8 3.3 9.0 133 28
P <0.005 NS NS NS NS <0.05 NS
B (N = 7)
0.1 M Na2HPO4
Mean 20.7 7.0 2.34 1.07 407.0 121.7 12.8 18.8 37.1 19.3 62.9 104.7 371 367
SEM 2.5 2.2 0.41 0.26 64.7 70.9 2.4 3.1 5.1 5.3 5.1 8.8 34 17
P <0.01 <0.05 <0.05 NS <0.05 0.005 NS
C (N = 6)
0.15 M NaHCO3
Mean 24.4 10.4 0.24 0,55 32.1 70.2 0.9 8.1 15.0 13.8 24.4 69.6 1101 404
SEM 5.2 4.1 0.07 0.12 9.9 13.9 0.3 2.4 3.3 2.6 8.0 16.2 235 39
P <0.02 <0.02 <0.05 <0.02 NS <0.02 <0.05
D (N 6)
0.7 M NaHCO3
Mean 22,4 12.4 2.55 2.47 462.6 406.3 13.5 21.7 44.1 37.3 85.0 119.4 477 413
SEM 2.8 2.5 0.67 0.72 85.5 100.2 2.9 4.7 8.9 6.6 14.5 18.9 54 39
P <0.02 NS NS NS NS NS NS
a Abbreviations are: C, control kidney; F, experimental kidney; C1, inulin clearance; V, urinary flow rate; UNaV, absolute rate of sodium
excretion; %ENa, percentage of filtered sodium excreted; UKV, absolute rate of potassium excretion; %EK, percentage of filtered potassium
excreted; Uosm, urinary osmolality.
Table 2. Urinary acidification and bicarbonate handling during 0.1 si Na2SO4 infusion
C F
UHCO
mEqi
liter
C E %E5503C E
UNH3V
p.Eq/min
C E
UNH V/
GFk
pEq/100
ml
C E
T.T.A.
pEqiminC F
T.T.A./
GFR
pEq/100
ml
C F
N.A.E.
p.Eq/min
C E
N.A.E./
GFR q/
100 ml
C F
pH
Blood
pCO2
mm
Hg
HCO3
mEq/
liter
Group A
0.1 M Na2SO4
(N =6)
Mean 5.39 6,61 0.33 7.81 0,07 4.17 12.5 3,5 82.0 48.5 6.9 1.4 42.0 23.4 19.1 —1.6 135.4 16.2 7.25 36.1 16.0
SEM 0.26 0.39 0.14 3.02 0.03 1.55 1.9 0.8 18.5 19.3 2.1 0.8 10.6 13.2 4.0 4.8 29.4 61.5 0.03 2.1 0.7
P <0.01 <0.05 <0.05 <0.01 <0.05 <0.02 <0.05 <0.02 <0.05
Abbreviations are as in Table I, and: U, urinary pH; UHc03, urine bicarbonate concentration; %EHco, percentage of filtered bicarbonate
excreted; UNH3V, absolute rate of ammonia excretion; UNH3V/GFR, ammonia excretion rate corrected for 100 ml GFR; T.T.A., absolute rate of
titratable acid excretion; T.T.AJGFR, titratable acid excretion corrected for 100 ml GFR; N.A.E., net acid excretion rate; N ,A.F./GFR, net acid
excretion corrected for 100 ml GFR.
mosmlkg H20 compared to the control kidney: 1101 235
mosm/kg H20, P < 0.05 (Table 1).
in contrast to the marked defect in sodium reabsorption and
urinary concentrating mechanism, the ability of the ischemic
kidney to secrete potassium was preserved (Table 1). In fact,
fractional potassium excretion was significantly higher in the
ischemic kidney than in the control kidney of all experimental
groups (Table 1) and was appropriately suppressed following
amiloride administration. Thus, acute renal ischemia in the dog
does not interfere with tubular secretion of potassium.
Tubular reabsorption of bicarbonate
Tubular bicarbonate reabsorption was evaluated by plotting
the rate of bicarbonate reabsorption corrected for GFR
(THCO3/liter GFR) versus plasma bicarbonate concentrations
in groups A—D. Data are presented in Figure 1 which demon-
strate a comparable degree of bicarbonate reabsorption for both
the control and ischemic kidneys over a wide range of plasma
bicarbonate concentrations. Additionally, Tm of bicarbonate
corrected for GFR (TmHCO3/liter GFR) was calculated for the
individual urine collections in the animals infused with 0.7 M
NaHCO3 (group D), where plasma bicarbonate had reached the
highest level among the experimental groups. These values
were: ischemic, 19.2 2.6 mmole/liter GFR; control, 23.2 1.9
mmole/liter GFR; P NS. Thus, acute renal ischemia was not
associated with a measureable decrease in maximal bicarbonate
reabsorptive capacity per nephron. Yet a small leak in proximal
bicarbonate reabsorption, in particular at low plasma bicarbon-
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Table 3. Renal acidification and bicarbonate excretion data during: neutral phosphate infusion, Group B; 0.15 M NaHCO3 infusion, Group C;
and 0.7 M NaHCO3 infusion, Group D.
UHCO3
mEqlliter
UHCO3V
p.Eq/min %EHcO3
U-B PCO2
mm Hg
Blood
PCO2
HCO
mEqi
C E C F C E C E C E pH mm Hg liter
Group B
0.1 M Na2HPO4
Mean 6.55 6.89 7.6 12.1 19.4 14.8 5.4 12.7 37.2 13.8 7.32 41.6 21.0
SEM 0.06 0.11 1.1 2.2 6.0 4.9 2.1 4.0 6.8 4.1 0.02 1.4 0.7
P <0.02 NS NS <0.05 <0.01
Group C
0.15 M NaHCO3
Mean 7.35 7.66 51.2 40.6 9.6 19.0 2.4 16.2 40.1 —1.9 7.39 36.5 21.7
SEM 0.14 0.09 11.8 20.7 2.1 3.3 0.6 3.9 14.8 3.4 0.05 2.8 1.4
P NS NS <0.05 <0.02 <0.05
Group D
0.7 M NaHCO3
Mean 7.97 7.94 177.4 130.3 369.4 275.2 45.4 56.6 26.6 11.4 7.56 47.3 43.3
SEM 0.03 0.04 27.4 29.9 41.9 69.2 3.2 7.0 7.9 8.8 0.03 3.0 4.0
P NS <0.05 NS NS <0.02
Abbreviations are the same as Table 2, and: UHCO3V, absolute rate of bicarbonate excretion; and U-B PCO2, urine to blood PCO2 gradient.
ate concentrations (Fig. 1), cannot be completely ruled out by
the relatively insensitive clearance methodology.
Distal acidification
Table 2 summarizes the data obtairied during sodium sulphate
infusion, (group A). These animals were mildly acidotic (arterial
plasma pH 7.25 0.03, bicarbonate 16.0 0.7 mEqlliter).
Minimal urine pH was significantly higher in the ischemic
kidney compared to the control (pH = 6.61 0.39 vs. 5.39
0.26, P < 0.01).
Absolute rates of ammonia and titratable acid excretion as
well as values corrected per 100 ml GFR were significantly
lower in the ischemic compared to control kidney (Table 2).
Calculated net acid excretion was 19.05 3.99 Eq/min in the
control kidney and was practically abolished in the ischemic
kidney: —1.63 4.84 Eq/min, P < 0.02. These findings
strongly suggest a defect in distal acidification.
U-B PCO2 difference in animals infused with neutral phos-
phate solution (group B) was significantly reduced in the
ischemic kidney (13.8 4.1 mm Hg) compared to control
kidney (37.2 6.8 mm Hg, P < 0.01). Mean urinary phosphate
concentrations were comparable in both kidneys (ischemic:
95.4 16.9 mmol/liter; control: 128.7 14.7 mmol/liter, P =
NS). Although absolute rate of phosphate excretion was lower
in the ischemic kidney (91.2 28.7 tmol1min) compared to the
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control kidney (282.6 39.3 xmol/min, P < 0.005) fractional
excretion of phosphate was not different in the control and
ischemic kidneys. Figure 2 demonstrates the relationship of
U-B PCO2 versus urinary phosphate concentration in the indi-
vidual experiments in group B. With the exception of one
experiment, U-B PCO2 was lower in the ischemic kidney for
any given urinary phosphate concentration compared to values
obtained in the control kidney.
To evaluate U-B PCO2 difference during bicarbonate infu-
sion, two basic protocols were used in accordance with meth-
ods employed by Tam et al [11], In the euvolemic, isotonic
bicarbonate infusion group, mean U-B PCO2 difference was
abolished in the ischemic kidney (—1.9 3.4 mm Hg) compared
to normal kidney (40 14.8 mm Hg, P < 0.05). This occurred
despite a similar bicarbonate concentration in both kidneys
(ischemic: 40.6 8.4 mEq/liter; control: 51.2 11.8 mEq/liter;
P NS) and a higher level of both absolute and fractional
bicarbonate excretion in the ischemie kidney (Table 3). In the
group infused with hypertonic bicarbonate solution (group D),
U-B PCO2 difference was lower in the ischemic than in the
control kidney (Table 3). However, mean urine bicarbonate
concentration was also lower in the ischemic kidney compared
to control. Because of the dependence of U-B PCO2 on urinary
bicarbonate concentration 112—14], the individual measure-
ments of U-B PCO2 in this group were plotted against UHCO3
(Fig. 3). Notice that the regression lines for both the ischemic
and control kidneys have an identical slope (ischemic: U-B
PCO2 =
—19.4 + 0.24 UHCO3, control: U-B PCO2 = —16.3 +
0.24 UHCO1, P NS). Thus, for comparable levels of urine
bicarbonate concentration during hypertonic bicarbonate infu-
sion the values of U-B PCO2 for the control and isehemic
kidney overlap. This interesting finding will be further dis-
cussed in the next section.
Factors determining U-B PCO2 difference during bicarbonate
infusion
While U-B PCO2 difference was completely abolished in the
ischemic kidney during isotonic bicarbonate infusion (group C),
the administration of hypertonic bicarbonate solution (group D)
resulted in a comparable U-B PCO2/UHCO relationship in
both kidneys. If, indeed, U-B PCO, difference serves as an
index of distal H ion secretion, these results might seem
contradictory. Two approaches were therefore taken: first, to
evaluate the factors determining U-B PCO2 difference during
hypertonic bicarbonate infusion versus that seen during the
infusion of isotonic bicarbonate solution; second, to study distal
H ion secretion in the animals infused with hypertonic bicar-
bonate solution and amiloride administration, which further
blunts acid excretion. Figure 3 demonstrates the highly signif-
icant correlation between U-B PCO2 difference and UHCO
obtained both for the control and ischemic kidney when
hypertonic bicarbonate was given. In contrast, such a correla-
tion could not be found either in the control or in the ischemic
kidney in the group infused with isotonic bicarbonate solution.
In the latter group, however, a highly significant correlation was
obtained in the control kidney when U-B PCO2 was plotted
against absolute sodium excretion, which is presumably an
index of distal sodium delivery (U-B PCO2 = 5.2 + 1.25 U NaY,
r = 0,91, P < 0.001, Fig. 4). Similar results were reported by
Tam et al. 111]. These findings imply that in the euvolemic state,
U-B PCO2 difference is determined mainly by distal delivery
and reabsorption of sodium and is not related to urine bicar-
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bonate concentration. In contrast, during volume expansion
and when urine bicarbonate concentration is very high (group
D), urine bicarbonate concentration appears to be the major
determinant of U-B PCO2 [11].
Finally, during isotonic bicarbonate infusion, no correlation
could be found between U-B PCO2 and UNaV in the ischemic
kidney (r = 0.08, P = NS, Fig. 5). This occurred despite an
adequate delivery of sodium to the distal nephron of the
ischemic kidney, as assessed by the high rate of absolute
sodium excretion. The lack of correlation may be thus related to
a defect in distal sodium reabsorption or alternatively, to a
primary failure of the distal nephron to secrete H ions.
In group E, amiloride was administered during hypretonic
bicarbonate infusion. Systemic acid—base data in this group
were as follows: arterial blood pH was 7.52 0.03; bicarbonate
concentration 34.7 2.3 mEq/liter; PCO2 was 41.3 2.1 mm
Hg. These results were not statistically different from the values
obtained in group D, where only hypertonic HCO3 solution was
given (Table 3). However, mean serum potassium concentra-
tion was significantly higher in the group infused with amiloride
(group E: 3.32 0.15 mEq/liter; group D: 2.6 0.4 mEq/liter;
P < 0.02). Table 4 presents the effects of amiloride administra-
tion on urinary excretion of sodium, potassium and bicarbonate
as well as on urinary acidification patterns in the ischemic and
control kidneys of group E. The data is compared to that of the
ischemic and control kidneys in group D where only hypertonic
bicarbonate was given. Amiloride administration resulted in a
sharp decrease in absolute potassium excretion as well as in
fractional urinary potassium excretion both in ischemic and
control kidney (Table 4). However, urinary pH, bicarbonate
concentration, U-B PCO2 and absolute as well as fractional
bicarbonate excretion, in the two kidneys, were not statistically
different when compared to group D (Table 4). Thus, despite a
marked effect on renal potassium handling, amiloride did not
change urinary bicarbonate excretion patterns. As in group D,
a highly significant correlation was obtained when U-B PCO2
was plotted against urinary bicarbonate concentration in the
control kidney (U-B PCO2 = —13.3 + 0.24 UHCO3, r 0.764,
P < 0.001). The correlation coefficient for the ischemic kidney
was lower but significant (U-B PCO2 = —7.1 + 0.17 UHCO3, r
= 0.464, P < 0.05). Furthermore, neither the slope of the lines
nor their intercepts differed in both kidneys. Thus, amiloride
Table 4. Urinary acidification and clearance data in the ischemic
kidneys and the control kidneys during 0.7 M NaHCO3 infusion
(group D) and 0.7 M NaHCO3 + amiloride (group E)
Group D Group E P
Ischemic kidney
GFR mI/mm 12.4 2.5 9.8 2.07 NS
UNaV p.Eq/min 406.3 100.2 342.0 139.7 NS
%ENa 21.7 4.7 26.1 6.0 NS
UKV p.Eq/min 37.3 6.6 10.1 1.9 <0.005
%EK 119.4 18.9 37.2 8.1 <0.005
UpH 7.94 0.04 7.91 0.06 NS
U03 mEqiliter 130.3 29.9 103.5 11.7 NS
Uco3V p.Eq/min 275.2 69.2 204.6 40.7 NS
%Ec03 56.6 7.0 65.1 9.7 NS
U-B PCO2 mm Hg 11.4 8.8 12.2 3.8 NS
Control kidney
GFR mI/mm 22.4 2.8 26.6 4.0 NS
UNaV pEqimin 462.6 85.5 613.2 159.8 NS
%ENa 13.5 2.9 15.0 3.3 NS
UKV pEqimin 44.1 8.9 16.8 10.1 <0.02
%EK 85.0 14.5 20.2 4.8 <0.005
UpH 7.97 0.03 8.01 0.03 NS
UHCO3 mEq/liter 177.4 27.4 160.5 15.1 NS
Uco3V pEqlmin 369.4 41.9 474.1 106.9 NS
%EHC03 45.4 3.2 51.1 8.0 NS
U-B PCO2 mm Hg 26.6 7.9 24.5 4.8 NS
did not prevent the generation of a steep U-B PCO2 gradient in
the control and ischemic kidneys of animals with highly alkaline
urine due to hypertonic bicarbonate infusion.
Discussion
The data obtained in our study demonstrate for the first time
the presence of a defect in distal acidification in an ischemic
model of acute renal failure. This conclusion is based on the
following findings: first, the ischemic kidney was unable to
decrease urinary pH adequately in response to Na2SO4 and
mineralocorticoid administration. Furthermore, ammonia and
titratable acid excretions as well as net acid excretion corrected
for GFR were substantially lower in the ischemic kidney during
the latter procedure. Second, U-B PCO2 difference, considered
to be an index of distal H ion secretion [15, 16] was reduced in
the ischemic kidney during isotonic bicarbonate infusion as well
as during infusion of neutral phosphate solution. Finally, Tm of
HCO3 corrected for GFR was unaltered following acute renal
ischemia in the dog. Thus, our findings are at variance with
those reported by Westenfelder et al [6] in rats with
glycerol—induced acute renal failure. Their study demonstrated
that distal acidification remained intact, whereas Tm/GFR of
bicarbonate was substantially decreased following glycerol ad-
ministration. Apart from species differences, these findings may
suggest that acute ischemia predominantly affects the distal
portions of the nephron whereas glycerol administration inter-
feres mainly with the function of the proximal tubule.
The combination of inability to lower urinary pH during
sulphate administration and impaired U-B PCO2 generation
following buffer and isotonic bicarbonate infusions is compati-
ble with either a primary failure of the proton pump (secretory
defect) or, alternatively, with a voltage type defect [16]. The
finding that the impairment in U-B PCO2 difference persisted
during buffer infusion, and that following sulphate administra-
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Fig. S. U-B PCO2 as a function of absolute urinary sodium excretion in
the ischemic kidney during administration of isotonic bicarbonate
solution (group C). In contrast to the control kidney (Fig. 4) no
significant correlation was obtained for the ischemic kidney, r = 0.076,
P = NS.
Abbreviations are the same as Tables 1 through 3.
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tion urinary pH in the ischemic kidney was >5.5, tends to
exclude the possibility of a gradient type defect caused by
increased backleak of H ions [16]. It has been recently
demonstrated that in the classic gradient lesion produced by
amphotericin, the ability to lower urinary pH during Na2SO4
infusion is preserved [17]. Furthermore, systemic factors
known to interfere with urinary acidification, such as changes in
serum aldosterone levels [18], serum potassium [191, changes in
systemic pH [20], and extracellular volume status [211 may also
be excluded since they should have affected similarly the
experimental as well as the control kidneys. The possibility that
a secretory defect or, alternatively, a voltage type defect may
be responsible for the impairment in distal acidification in our
model is further supported by evaluating the data obtained
during isotonic bicarbonate infusion (group C). In agreement
with the recently reported results by Tam et al [ii] we have also
demonstrated a highly significant correlation between U-B
PCO2 and absolute excretion of sodium, an index of distal
sodium delivery in the control kidney of the euvolemic group
(Fig. 4). The implication from their data as well as from the
present study is that the rate of distal sodium reabsorption or
"avidity" rather than urinary bicarbonate concentration is the
major factor determining U-B PCO2 difference in the euvolemic
state. The failure of the ischeniic kidney to increase U-B PCO2
difference despite an adequate delivery of sodium to the distal
nephron (Fig. 5) may, therefore, result from a primary defect in
the proton pump (secretory defect). Alternatively, a defect in
distal sodium reabsorption, similar to that produced by
amiloride [22, 23] may lead to decreased luminal electronegativ-
ity, and thus interfere with distal H ion secretion (voltage
defect). The finding that sodium reabsorption is impaired in the
ischemic kidney during euvolemia would favor the second
alternative, that is voltage defect. However, the reduced
luminal electronegativity in the voltage type defect is usually
associated with a decrease in potassium excretion as well [16].
This is in contrast to a primary secretory defect where potas-
sium excretion remains intact. Our data demonstrate that acute
renal ischemia is not associated with a decrease in potassium
excretion. In fact, fractional potassium excretion was increased
in the ischemic kidney compared to the control in all experi-
mental groups, Taken together, these results tend to support a
secretory rather than a voltage type defect. We cannot rigor-
ously exclude, however, a combination of voltage type defect
with an increased potassium excretion resulting from a tubular
leak of potassium due to the ischemic damage. Yet, the appro-
priate responsiveness of urinary potassium excretion to
amiloride in the ischemic kidney would suggest sparing of the
"voltage" mechanism following ischemia. A similar secretory
defect has been recently reported in patients following kidney
transplantation and was considered as an early sign of allograft
rejection [24]. Our data would suggest that such a defect may
also be the consequence of the prolonged renal ischemia and the
acute tubular necrosis of the transplanted kidney.
Although our data localize the defect to the distal nephron,
the possibility of a small proximal bicarbonate leak must he
considered as well. As already pointed out, the finding of
comparable Tm/GFR of bicarbonate in both kidneys cannot
completely rule out a proximal bicarbonate leak. Furthermore,
a defect in proximal reabsorption would interfere with the
achievement of minimal urinary pH during sulphate infusion in
the ischemic kidney. However, such a proximal leak, as the
only perturbation, would tend to raise urinary PCO2 during
bicarbonate and phosphate infusions because distal acidifica-
tion was intact. The fact that such a concomitant proximal
defect, if indeed it existed, was not a major one is further
supported by the following findings: during isotonic bicarbonate
infusion (mean plasma bicarbonate 21.7 1.4 mEq/liter), the
difference in fractional bicarbonate excretion between the con-
trol and ischemic kidneys was 13.8 percent (Table 3), a border-
line value that is not commensurate with a major proximal leak.
In addition, the absence of glycosuria in the latter group further
diminishes the likelihood of a major defect in proximal rabsorp-
tion.
The results of the present investigation may also have several
implications regarding the mechanism of generation of U-B
PCO2 difference in highly alkaline urine. This is well demon-
strated by comparing the results obtained in the groups infused
with bicarbonate solutions (groups C, D and E). Our data show
that during isotonic bicarbonate infusion, U-B PCO2 difference
was completely abolished in the ischemic kidney, whereas in
the control kidney, a steep U-B PCO2 gradient was generated
which was highly correlated with distal sodium delivery. In
contrast, during hypertonic bicarbonate infusion and a highly
alkaline urine, a significant correlation could be obtained be-
tween U-B PCO2 and urine bicarbonate concentration, both for
the control and the ischemic kidneys. Furthermore, administra-
tion of amiloride, an agent which has been previously shown to
decrease H ion secretion in the cortical collecting duct 125]
and turtle bladder [221, did not alter urinary bicarbonate excre-
tion and the U-B PCO2/UHCO3 relationship in highly alkaline
urine despite a major effect on urinary potassium excretion.
The fact that despite the defect in distal acidification the U-B
PCO2!UHCO3 relationship was within the normal range during
hypertonic bicarbonate infusion is baffling. Such a finding is
difficult to explain if one assumes that the ischemic damage
resulted in a similar tubular impairment also in the group
infused with hypertonic bicarbonate solution. It is possible that
the defect in distal acidification was reversed by the massive
HCO1 infusion. Alternatively, it might be speculated that the
generation of U-B PCO2 difference during extreme increase in
urinary bicarbonate concentration in the ischemic kidney may
be related to other factors in addition to distal H ion secretion.
The physicochemical properties of the bicarbonate were orig-
inally proposed by Maren [12, 261 and Arruda and co-workers
[13, 141 as an explanation for the high PCO2 in alkaline urine
independent of H ion secretion. However, the role played by
the latter phenomenon under "in vivo" conditions is still
controversial [27]. Whether or not such an "ampholyte effect"
may be invoked as the chemical basis for our findings awaits
further clarification.
In summary, we have shown that acute renal ischemia in the
dog is associated with impaired tubular H ion secretion
predominantly in the distal nephron. This defect appears to be
most likely of a secretory type.
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